Sec. 5. (a) The written informed request must be on a form prepared by and obtained from the medical licensing board of Indiana and must be in substance as follows:
WRITTEN INFORMED REQUEST
FOR PRESCRIPTION OF AMYGDALIN
(LAETRILE) FOR MEDICAL
TREATMENT
Patient's name __________________________
Address _________________________________
Age ________ Sex ___________
Name and address of prescribing physician
_________________________________________
Malignancy, disease, illness, or physical condition diagnosed for medical treatment by amygdalin (laetrile) or the use of amygdalin as a dietary supplement:
________________________________________
________________________________________
My physician has explained the following to me:
(1) That the manufacture and distribution of amygdalin (laetrile) has been banned by the Federal Food and Drug Administration.
(2) That neither the American Cancer Society, the American Medical Association, nor the Indiana State Medical Association recommend use of amygdalin (laetrile) in the treatment of a malignancy, a disease, an illness, or a physical condition.
(3) That there are alternative recognized treatments for the malignancy, disease, illness, or physical condition from which I suffer that my physician has offered to provide for me, including the following:
(Here describe)
______________________________________
______________________________________
Notwithstanding this explanation, I request prescription and use of amygdalin (laetrile):
(1) in the medical treatment of the malignancy, disease, illness, or physical condition from which I suffer ( ); or
(2) as a dietary supplement ( ).
(Check (1) or (2))
________________________________________
Patient or person signing for patient
ATTEST:
__________________________________
Prescribing physician
(b) A copy of the written informed request shall be forwarded after execution to the medical licensing board of Indiana for appropriate filing.
[Pre-1993 Recodification Citation: 16-8-8-5.]
As added by P.L.2-1993, SEC.25.
